Search research articles
Contact Us
Filters
Showing results (341-350 of 692) with videos related to
Page
of 70
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1995
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms
H I Scher, A Sarkis, V Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma
J A McCaffrey, S Hilton, M Mazumdar, et al.
Clinical Genitourinary Cancer
|
February 15, 2020
A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer
Deaglan J McHugh, Jay Chudow, Mia DeNunzio, et al.
The Lancet. Oncology
|
August 9, 2014
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial
Karim Fizazi, Howard I Scher, Kurt Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2000
Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer
M J Zelefsky, W K Kelly, H I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1994
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors
R J Motzer, D F Bajorin, L H Schwartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2016
The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population
Glenn Heller, Karim Fizazi, Robert McCormack, et al.
JAMA Neurology
|
September 14, 2019
Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
Kjetil Bjornevik, Kassandra L Munger, Marianna Cortese, et al.
Clinical Genitourinary Cancer
|
March 13, 2022
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
Aseem Anand, Glenn Heller, Joseph Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Rapid androgen cycling as treatment for patients with prostate cancer
David Feltquate, Luke Nordquist, Caitlin Eicher, et al.
Page
of 70
Search research articles
Search
Showing results (341-350 of 692) with videos related to
Sort By:
Page
of 70
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1995
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms
H I Scher, A Sarkis, V Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinoma
J A McCaffrey, S Hilton, M Mazumdar, et al.
Clinical Genitourinary Cancer
|
February 15, 2020
A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer
Deaglan J McHugh, Jay Chudow, Mia DeNunzio, et al.
The Lancet. Oncology
|
August 9, 2014
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial
Karim Fizazi, Howard I Scher, Kurt Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2000
Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer
M J Zelefsky, W K Kelly, H I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1994
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors
R J Motzer, D F Bajorin, L H Schwartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2016
The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population
Glenn Heller, Karim Fizazi, Robert McCormack, et al.
JAMA Neurology
|
September 14, 2019
Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
Kjetil Bjornevik, Kassandra L Munger, Marianna Cortese, et al.
Clinical Genitourinary Cancer
|
March 13, 2022
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
Aseem Anand, Glenn Heller, Joseph Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Rapid androgen cycling as treatment for patients with prostate cancer
David Feltquate, Luke Nordquist, Caitlin Eicher, et al.
Page
of 70